{"ACN": {"Ticker": "ACN", "Company": "Accenture", "Sector": "Information Technology", "Updated": "2022-12-12", "Rating": [{"Date": "2022-12-12", "Rating": "Downgrade", "Organization": "Piper Sandler", "Rating_Change": "Neutral to Underweight", "Target_Change": "$268"}], "Score": -1.0, "Cumulative_Rating": "Underperform", "Number_of_Analysts": 1, "Period": "180 days", "Letter_Rating": "D", "Analists": ["Piper Sandler"], "Price_Target": 268.0}, "ADI": {"Ticker": "ADI", "Company": "Analog Devices", "Sector": "Information Technology", "Updated": "2022-12-12", "Rating": [{"Date": "2022-12-12", "Rating": "Initiated", "Organization": "Susquehanna", "Rating_Change": "Positive", "Target_Change": "$205"}, {"Date": "2022-12-09", "Rating": "Reiterated", "Organization": "Cowen", "Rating_Change": "Outperform", "Target_Change": "$190 to $200"}, {"Date": "2022-11-23", "Rating": "Reiterated", "Organization": "Cowen", "Rating_Change": "Outperform", "Target_Change": "$180 to $190"}, {"Date": "2022-11-16", "Rating": "Resumed", "Organization": "Credit Suisse", "Rating_Change": "Neutral", "Target_Change": "$185"}, {"Date": "2022-10-24", "Rating": "Downgrade", "Organization": "Barclays", "Rating_Change": "Overweight to Equal Weight", "Target_Change": "$180 to $140"}, {"Date": "2022-10-11", "Rating": "Initiated", "Organization": "Cowen", "Rating_Change": "Outperform", "Target_Change": "$180"}], "Score": 0.83, "Cumulative_Rating": "Outperform", "Number_of_Analysts": 6, "Period": "180 days", "Letter_Rating": "B", "Analists": ["Susquehanna", "Cowen", "Credit Suisse", "Barclays"], "Price_Target": 183.33}, "BAX": {"Ticker": "BAX", "Company": "Baxter International", "Sector": "Health Care", "Updated": "2022-12-12", "Rating": [{"Date": "2022-12-12", "Rating": "Downgrade", "Organization": "Citigroup", "Rating_Change": "Buy to Neutral", "Target_Change": "$64 to $58"}, {"Date": "2022-10-18", "Rating": "Initiated", "Organization": "Barclays", "Rating_Change": "Overweight", "Target_Change": "$64"}, {"Date": "2022-10-12", "Rating": "Initiated", "Organization": "Jefferies", "Rating_Change": "Hold", "Target_Change": "$62"}], "Score": 0.33, "Cumulative_Rating": "Neutral", "Number_of_Analysts": 3, "Period": "180 days", "Letter_Rating": "C", "Analists": ["Citigroup", "Jefferies", "Barclays"], "Price_Target": 61.33}, "BDX": {"Ticker": "BDX", "Company": "Becton Dickinson", "Sector": "Health Care", "Updated": "2022-12-12", "Rating": [{"Date": "2022-12-12", "Rating": "Upgrade", "Organization": "Citigroup", "Rating_Change": "Sell to Neutral", "Target_Change": "$221 to $250"}], "Score": 1.0, "Cumulative_Rating": "Outperform", "Number_of_Analysts": 1, "Period": "180 days", "Letter_Rating": "B", "Analists": ["Citigroup"], "Price_Target": 250.0}, "BBY": {"Ticker": "BBY", "Company": "Best Buy", "Sector": "Consumer Discretionary", "Updated": "2022-12-12", "Rating": [{"Date": "2022-12-12", "Rating": "Upgrade", "Organization": "Goldman", "Rating_Change": "Sell to Neutral", "Target_Change": "$59 to $83"}, {"Date": "2022-10-19", "Rating": "Downgrade", "Organization": "Evercore ISI", "Rating_Change": "Outperform to In-line", "Target_Change": "$80 to $70"}], "Score": -0.5, "Cumulative_Rating": "Neutral", "Number_of_Analysts": 2, "Period": "180 days", "Letter_Rating": "C", "Analists": ["Goldman", "Evercore ISI"], "Price_Target": 76.5}, "TECH": {"Ticker": "TECH", "Company": "Bio-Techne", "Sector": "Health Care", "Updated": "2022-12-12", "Rating": [{"Date": "2022-12-12", "Rating": "Upgrade", "Organization": "Citigroup", "Rating_Change": "Neutral to Buy", "Target_Change": "$81.25 to $100"}, {"Date": "2022-12-07", "Rating": "Initiated", "Organization": "RBC Capital Mkts", "Rating_Change": "Sector Perform", "Target_Change": "$89"}], "Score": 1.0, "Cumulative_Rating": "Outperform", "Number_of_Analysts": 2, "Period": "180 days", "Letter_Rating": "B", "Analists": ["RBC Capital Mkts", "Citigroup"], "Price_Target": 94.5}, "CTRA": {"Ticker": "CTRA", "Company": "Coterra", "Sector": "Energy", "Updated": "2022-12-12", "Rating": [{"Date": "2022-12-12", "Rating": "Downgrade", "Organization": "Truist", "Rating_Change": "Buy to Hold", "Target_Change": "$26"}, {"Date": "2022-12-07", "Rating": "Downgrade", "Organization": "Citigroup", "Rating_Change": "Neutral to Sell", "Target_Change": "$27 to $23"}, {"Date": "2022-11-30", "Rating": "Downgrade", "Organization": "Tudor, Pickering, Holt & Co.", "Rating_Change": "Buy to Hold", "Target_Change": ""}, {"Date": "2022-11-07", "Rating": "Upgrade", "Organization": "Wolfe Research", "Rating_Change": "Underperform to Peer Perform", "Target_Change": ""}, {"Date": "2022-10-25", "Rating": "Resumed", "Organization": "Stifel", "Rating_Change": "Buy", "Target_Change": "$40"}, {"Date": "2022-10-19", "Rating": "Initiated", "Organization": "Jefferies", "Rating_Change": "Hold", "Target_Change": "$32"}], "Score": 0.0, "Cumulative_Rating": "Neutral", "Number_of_Analysts": 6, "Period": "180 days", "Letter_Rating": "C", "Analists": ["Citigroup", "Jefferies", "Wolfe Research", "Truist", "Stifel", "Tudor, Pickering, Holt & Co."], "Price_Target": 30.25}, "GPS": {"Ticker": "GPS", "Company": "Gap", "Sector": "Consumer Discretionary", "Updated": "2022-12-12", "Rating": [{"Date": "2022-12-12", "Rating": "Upgrade", "Organization": "Goldman", "Rating_Change": "Neutral to Buy", "Target_Change": "$18"}], "Score": 2.0, "Cumulative_Rating": "Significant Outperform", "Number_of_Analysts": 1, "Period": "180 days", "Letter_Rating": "A", "Analists": ["Goldman"], "Price_Target": 18.0}, "GPC": {"Ticker": "GPC", "Company": "Genuine Parts", "Sector": "Consumer Discretionary", "Updated": "2022-12-12", "Rating": [{"Date": "2022-12-12", "Rating": "Downgrade", "Organization": "Goldman", "Rating_Change": "Neutral to Sell", "Target_Change": "$124 to $147"}], "Score": -1.0, "Cumulative_Rating": "Underperform", "Number_of_Analysts": 1, "Period": "180 days", "Letter_Rating": "D", "Analists": ["Goldman"], "Price_Target": 147.0}, "ILMN": {"Ticker": "ILMN", "Company": "Illumina", "Sector": "Health Care", "Updated": "2022-12-12", "Rating": [{"Date": "2022-12-12", "Rating": "Downgrade", "Organization": "Citigroup", "Rating_Change": "Neutral to Sell", "Target_Change": "$200 to $180"}, {"Date": "2022-12-07", "Rating": "Initiated", "Organization": "RBC Capital Mkts", "Rating_Change": "Outperform", "Target_Change": "$282"}, {"Date": "2022-10-04", "Rating": "Upgrade", "Organization": "SVB Leerink", "Rating_Change": "Mkt Perform to Outperform", "Target_Change": "$220 to $270"}, {"Date": "2022-09-28", "Rating": "Upgrade", "Organization": "Evercore ISI", "Rating_Change": "In-line to Outperform", "Target_Change": "$170 to $250"}], "Score": 1.0, "Cumulative_Rating": "Outperform", "Number_of_Analysts": 4, "Period": "180 days", "Letter_Rating": "B", "Analists": ["RBC Capital Mkts", "Citigroup", "SVB Leerink", "Evercore ISI"], "Price_Target": 245.5}, "JCI": {"Ticker": "JCI", "Company": "Johnson Controls", "Sector": "Industrials", "Updated": "2022-12-12", "Rating": [{"Date": "2022-12-12", "Rating": "Downgrade", "Organization": "BofA Securities", "Rating_Change": "Buy to Neutral", "Target_Change": "$85 to $72"}], "Score": -1.0, "Cumulative_Rating": "Underperform", "Number_of_Analysts": 1, "Period": "180 days", "Letter_Rating": "D", "Analists": ["BofA Securities"], "Price_Target": 72.0}, "KLAC": {"Ticker": "KLAC", "Company": "KLA Corporation", "Sector": "Information Technology", "Updated": "2022-12-12", "Rating": [{"Date": "2022-12-12", "Rating": "Downgrade", "Organization": "Deutsche Bank", "Rating_Change": "Buy to Hold", "Target_Change": "$370 to $400"}], "Score": -1.0, "Cumulative_Rating": "Underperform", "Number_of_Analysts": 1, "Period": "180 days", "Letter_Rating": "D", "Analists": ["Deutsche Bank"], "Price_Target": 400.0}, "LH": {"Ticker": "LH", "Company": "LabCorp", "Sector": "Health Care", "Updated": "2022-12-12", "Rating": [{"Date": "2022-12-12", "Rating": "Downgrade", "Organization": "Citigroup", "Rating_Change": "Buy to Neutral", "Target_Change": "$275 to $250"}, {"Date": "2022-09-19", "Rating": "Downgrade", "Organization": "Argus", "Rating_Change": "Buy to Hold", "Target_Change": ""}], "Score": -1.0, "Cumulative_Rating": "Underperform", "Number_of_Analysts": 2, "Period": "180 days", "Letter_Rating": "D", "Analists": ["Citigroup", "Argus"], "Price_Target": 250.0}, "LRCX": {"Ticker": "LRCX", "Company": "Lam Research", "Sector": "Information Technology", "Updated": "2022-12-12", "Rating": [{"Date": "2022-12-12", "Rating": "Upgrade", "Organization": "Deutsche Bank", "Rating_Change": "Hold to Buy", "Target_Change": "$400 to $520"}, {"Date": "2022-10-20", "Rating": "Upgrade", "Organization": "Summit Insights", "Rating_Change": "Hold to Buy", "Target_Change": ""}, {"Date": "2022-10-20", "Rating": "Reiterated", "Organization": "Wells Fargo", "Rating_Change": "Equal Weight", "Target_Change": "$410 to $350"}, {"Date": "2022-10-20", "Rating": "Reiterated", "Organization": "JP Morgan", "Rating_Change": "Overweight", "Target_Change": "$640 to $515"}, {"Date": "2022-10-20", "Rating": "Reiterated", "Organization": "Jefferies", "Rating_Change": "Buy", "Target_Change": "$535 to $525"}, {"Date": "2022-10-20", "Rating": "Reiterated", "Organization": "Evercore ISI", "Rating_Change": "Outperform", "Target_Change": "$500 to $450"}, {"Date": "2022-10-20", "Rating": "Reiterated", "Organization": "DA Davidson", "Rating_Change": "Neutral", "Target_Change": "$400 to $375"}, {"Date": "2022-10-20", "Rating": "Reiterated", "Organization": "BofA Securities", "Rating_Change": "Buy", "Target_Change": "$460 to $405"}, {"Date": "2022-10-20", "Rating": "Reiterated", "Organization": "B. Riley Securities", "Rating_Change": "Neutral", "Target_Change": "$455 to $390"}], "Score": 1.11, "Cumulative_Rating": "Outperform", "Number_of_Analysts": 9, "Period": "180 days", "Letter_Rating": "B", "Analists": ["Summit Insights", "Jefferies", "B. Riley Securities", "Wells Fargo", "Evercore ISI", "DA Davidson", "BofA Securities", "Deutsche Bank", "JP Morgan"], "Price_Target": 441.25}, "LEG": {"Ticker": "LEG", "Company": "Leggett & Platt", "Sector": "Consumer Discretionary", "Updated": "2022-12-12", "Rating": [{"Date": "2022-12-12", "Rating": "Downgrade", "Organization": "Piper Sandler", "Rating_Change": "Neutral to Underweight", "Target_Change": "$31 to $24"}], "Score": -1.0, "Cumulative_Rating": "Underperform", "Number_of_Analysts": 1, "Period": "180 days", "Letter_Rating": "D", "Analists": ["Piper Sandler"], "Price_Target": 24.0}, "MU": {"Ticker": "MU", "Company": "Micron Technology", "Sector": "Information Technology", "Updated": "2022-12-12", "Rating": [{"Date": "2022-12-12", "Rating": "Downgrade", "Organization": "Deutsche Bank", "Rating_Change": "Buy to Hold", "Target_Change": "$60 to $55"}, {"Date": "2022-11-16", "Rating": "Initiated", "Organization": "Credit Suisse", "Rating_Change": "Outperform", "Target_Change": "$78"}, {"Date": "2022-10-14", "Rating": "Initiated", "Organization": "Loop Capital", "Rating_Change": "Buy", "Target_Change": "$70"}, {"Date": "2022-09-30", "Rating": "Upgrade", "Organization": "Summit Insights", "Rating_Change": "Hold to Buy", "Target_Change": ""}, {"Date": "2022-09-30", "Rating": "Reiterated", "Organization": "Stifel", "Rating_Change": "Hold", "Target_Change": "$56 to $54"}, {"Date": "2022-09-30", "Rating": "Reiterated", "Organization": "Piper Sandler", "Rating_Change": "Underweight", "Target_Change": "$50 to $45"}, {"Date": "2022-09-30", "Rating": "Reiterated", "Organization": "Needham", "Rating_Change": "Buy", "Target_Change": "$64 to $60"}, {"Date": "2022-09-30", "Rating": "Reiterated", "Organization": "Morgan Stanley", "Rating_Change": "Underweight", "Target_Change": "$56 to $49"}, {"Date": "2022-09-30", "Rating": "Reiterated", "Organization": "Mizuho", "Rating_Change": "Neutral", "Target_Change": "$56 to $52"}, {"Date": "2022-09-30", "Rating": "Reiterated", "Organization": "Deutsche Bank", "Rating_Change": "Buy", "Target_Change": "$68 to $60"}, {"Date": "2022-09-30", "Rating": "Reiterated", "Organization": "BofA Securities", "Rating_Change": "Neutral", "Target_Change": "$62 to $58"}, {"Date": "2022-09-30", "Rating": "Reiterated", "Organization": "BMO Capital Markets", "Rating_Change": "Outperform", "Target_Change": "$80 to $70"}, {"Date": "2022-09-26", "Rating": "Reiterated", "Organization": "Susquehanna", "Rating_Change": "Positive", "Target_Change": "$68 to $60"}, {"Date": "2022-09-21", "Rating": "Initiated", "Organization": "Stifel", "Rating_Change": "Hold", "Target_Change": "$56"}, {"Date": "2022-09-21", "Rating": "Downgrade", "Organization": "Mizuho", "Rating_Change": "Buy to Neutral", "Target_Change": "$75 to $56"}], "Score": 0.53, "Cumulative_Rating": "Outperform", "Number_of_Analysts": 15, "Period": "180 days", "Letter_Rating": "B", "Analists": ["Summit Insights", "Morgan Stanley", "Credit Suisse", "Loop Capital", "BofA Securities", "Stifel", "Needham", "Deutsche Bank", "Piper Sandler", "Susquehanna", "Mizuho", "BMO Capital Markets"], "Price_Target": 58.79}, "PKI": {"Ticker": "PKI", "Company": "PerkinElmer", "Sector": "Health Care", "Updated": "2022-12-12", "Rating": [{"Date": "2022-12-12", "Rating": "Upgrade", "Organization": "Citigroup", "Rating_Change": "Neutral to Buy", "Target_Change": "$135 to $170"}, {"Date": "2022-12-06", "Rating": "Upgrade", "Organization": "Cowen", "Rating_Change": "Market Perform to Outperform", "Target_Change": "$192 to $164"}, {"Date": "2022-11-28", "Rating": "Upgrade", "Organization": "Barclays", "Rating_Change": "Underweight to Equal Weight", "Target_Change": "$130 to $145"}], "Score": 2.0, "Cumulative_Rating": "Significant Outperform", "Number_of_Analysts": 3, "Period": "180 days", "Letter_Rating": "A", "Analists": ["Citigroup", "Cowen", "Barclays"], "Price_Target": 159.67}, "QCOM": {"Ticker": "QCOM", "Company": "Qualcomm", "Sector": "Information Technology", "Updated": "2022-12-12", "Rating": [{"Date": "2022-12-12", "Rating": "Downgrade", "Organization": "Wells Fargo", "Rating_Change": "Equal Weight to Underweight", "Target_Change": "$105"}, {"Date": "2022-11-16", "Rating": "Initiated", "Organization": "Credit Suisse", "Rating_Change": "Outperform", "Target_Change": "$150"}, {"Date": "2022-10-24", "Rating": "Initiated", "Organization": "HSBC Securities", "Rating_Change": "Buy", "Target_Change": "$180"}, {"Date": "2022-10-11", "Rating": "Reiterated", "Organization": "KeyBanc Capital Markets", "Rating_Change": "Overweight", "Target_Change": "$220 to $170"}], "Score": 1.0, "Cumulative_Rating": "Outperform", "Number_of_Analysts": 4, "Period": "180 days", "Letter_Rating": "B", "Analists": ["HSBC Securities", "Credit Suisse", "Wells Fargo", "KeyBanc Capital Markets"], "Price_Target": 151.25}, "ROK": {"Ticker": "ROK", "Company": "Rockwell Automation", "Sector": "Industrials", "Updated": "2022-12-12", "Rating": [{"Date": "2022-12-12", "Rating": "Downgrade", "Organization": "BofA Securities", "Rating_Change": "Buy to Neutral", "Target_Change": ""}], "Score": -1.0, "Cumulative_Rating": "Underperform", "Number_of_Analysts": 1, "Period": "180 days", "Letter_Rating": "D", "Analists": ["BofA Securities"], "Price_Target": 0}, "SO": {"Ticker": "SO", "Company": "Southern Company", "Sector": "Utilities", "Updated": "2022-12-12", "Rating": [{"Date": "2022-12-12", "Rating": "Upgrade", "Organization": "Wolfe Research", "Rating_Change": "Peer Perform to Outperform", "Target_Change": "$76"}, {"Date": "2022-10-24", "Rating": "Downgrade", "Organization": "BofA Securities", "Rating_Change": "Neutral to Underperform", "Target_Change": "$63 to $59"}, {"Date": "2022-10-20", "Rating": "Upgrade", "Organization": "KeyBanc Capital Markets", "Rating_Change": "Sector Weight to Overweight", "Target_Change": "$70"}], "Score": 0.67, "Cumulative_Rating": "Outperform", "Number_of_Analysts": 3, "Period": "180 days", "Letter_Rating": "B", "Analists": ["KeyBanc Capital Markets", "BofA Securities", "Wolfe Research"], "Price_Target": 68.33}, "TPR": {"Ticker": "TPR", "Company": "Tapestry", "Sector": "Consumer Discretionary", "Updated": "2022-12-12", "Rating": [{"Date": "2022-12-12", "Rating": "Upgrade", "Organization": "Goldman", "Rating_Change": "Neutral to Buy", "Target_Change": "$37 to $44"}], "Score": 2.0, "Cumulative_Rating": "Significant Outperform", "Number_of_Analysts": 1, "Period": "180 days", "Letter_Rating": "A", "Analists": ["Goldman"], "Price_Target": 44.0}, "TGT": {"Ticker": "TGT", "Company": "Target Corporation", "Sector": "Consumer Discretionary", "Updated": "2022-12-12", "Rating": [{"Date": "2022-12-12", "Rating": "Downgrade", "Organization": "Cleveland Research", "Rating_Change": "Buy to Neutral", "Target_Change": ""}, {"Date": "2022-12-06", "Rating": "Initiated", "Organization": "Bernstein", "Rating_Change": "Outperform", "Target_Change": "$190"}, {"Date": "2022-11-17", "Rating": "Upgrade", "Organization": "Piper Sandler", "Rating_Change": "Neutral to Overweight", "Target_Change": "$190 to $200"}, {"Date": "2022-11-17", "Rating": "Downgrade", "Organization": "Deutsche Bank", "Rating_Change": "Buy to Hold", "Target_Change": "$183 to $144"}, {"Date": "2022-11-17", "Rating": "Downgrade", "Organization": "BMO Capital Markets", "Rating_Change": "Outperform to Market Perform", "Target_Change": "$190 to $165"}, {"Date": "2022-10-18", "Rating": "Upgrade", "Organization": "Jefferies", "Rating_Change": "Hold to Buy", "Target_Change": "$170 to $185"}, {"Date": "2022-09-14", "Rating": "Initiated", "Organization": "KeyBanc Capital Markets", "Rating_Change": "Overweight", "Target_Change": "$200"}], "Score": 0.43, "Cumulative_Rating": "Neutral", "Number_of_Analysts": 7, "Period": "180 days", "Letter_Rating": "C", "Analists": ["Jefferies", "Cleveland Research", "Bernstein", "Deutsche Bank", "Piper Sandler", "BMO Capital Markets", "KeyBanc Capital Markets"], "Price_Target": 180.67}, "TDY": {"Ticker": "TDY", "Company": "Teledyne Technologies", "Sector": "Industrials", "Updated": "2022-12-12", "Rating": [{"Date": "2022-12-12", "Rating": "Upgrade", "Organization": "Morgan Stanley", "Rating_Change": "Underweight to Equal-Weight", "Target_Change": "$445 to $488"}], "Score": 1.0, "Cumulative_Rating": "Outperform", "Number_of_Analysts": 1, "Period": "180 days", "Letter_Rating": "B", "Analists": ["Morgan Stanley"], "Price_Target": 488.0}, "TT": {"Ticker": "TT", "Company": "Trane Technologies", "Sector": "Industrials", "Updated": "2022-12-12", "Rating": [{"Date": "2022-12-12", "Rating": "Downgrade", "Organization": "BofA Securities", "Rating_Change": "Neutral to Underperform", "Target_Change": "$160"}], "Score": -2.0, "Cumulative_Rating": "Significant Underperform", "Number_of_Analysts": 1, "Period": "180 days", "Letter_Rating": "E", "Analists": ["BofA Securities"], "Price_Target": 160.0}, "ULTA": {"Ticker": "ULTA", "Company": "Ulta Beauty", "Sector": "Consumer Discretionary", "Updated": "2022-12-12", "Rating": [{"Date": "2022-12-12", "Rating": "Downgrade", "Organization": "Goldman", "Rating_Change": "Buy to Neutral", "Target_Change": "$511 to $508"}, {"Date": "2022-12-02", "Rating": "Reiterated", "Organization": "Telsey Advisory Group", "Rating_Change": "Outperform", "Target_Change": "$510 to $575"}], "Score": 0.5, "Cumulative_Rating": "Outperform", "Number_of_Analysts": 2, "Period": "180 days", "Letter_Rating": "B", "Analists": ["Goldman", "Telsey Advisory Group"], "Price_Target": 541.5}, "UAA": {"Ticker": "UAA", "Company": "Under Armour (Class A)", "Sector": "Consumer Discretionary", "Updated": "2022-12-12", "Rating": [{"Date": "2022-12-12", "Rating": "Upgrade", "Organization": "Stifel", "Rating_Change": "Hold to Buy", "Target_Change": "$9 to $12"}, {"Date": "2022-11-01", "Rating": "Resumed", "Organization": "BofA Securities", "Rating_Change": "Neutral", "Target_Change": "$8"}, {"Date": "2022-10-21", "Rating": "Downgrade", "Organization": "Telsey Advisory Group", "Rating_Change": "Outperform to Market Perform", "Target_Change": "$12 to $8"}, {"Date": "2022-10-13", "Rating": "Initiated", "Organization": "Raymond James", "Rating_Change": "Mkt Perform", "Target_Change": ""}], "Score": -0.25, "Cumulative_Rating": "Neutral", "Number_of_Analysts": 4, "Period": "180 days", "Letter_Rating": "C", "Analists": ["Telsey Advisory Group", "Stifel", "Raymond James", "BofA Securities"], "Price_Target": 9.33}}